The European medicines regulatory network has developed training materials, guidance, tools and templates to strengthen national pharmacovigilance systems and support Member States in the implementation of best practice. These materials are publicly available and can be useful for marketing authorisation holders, healthcare professionals, patient and consumer organisations and academia.

In November 2013, national competent authorities initiated the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action to support pharmacovigilance operations in the European network, minimise duplication of work and make the best use of work sharing and resources. The European Medicines Agency (EMA) was a member of the project's General Advisory Board.

SCOPE developed training modules and best practice guides in key areas of pharmacovigilance for staff working at national competent authorities to further improve their skills and the capability of the EU pharmacovigilance network. SCOPE published the training materials in 2016.

The SCOPE website was decommissioned following project closure and EMA agreed to make the training materials available on its website. Stakeholders can use these publicly-available training materials, tools and templates to learn about best practice in pharmacovigilance and strengthen their pharmacovigilance systems.

The EU Network Training Centre (EU NTC), a joint training initiative established by the Heads of Medicines Agencies (HMA) and EMA, uses SCOPE learning materials to train assessors.

Users should bear in mind that the file size of some documents exceeds 30 megabytes.

Collection of adverse drug reactions

These training materials focus on national schemes for the spontaneous reporting of adverse drug reactions (ADRs) by healthcare professionals and patients. They aim to provide national competent authorities (NCAs) with a better understanding of available systems and practices for collecting ADRs.

CourseDetection of duplicates
DescriptionThe course provides a starting point for the development of a learning tool on duplicate detection processes specifically aimed at national competent authorities.
Main topics discussed
  • Management of duplicates and  examples of good practice
  • Importance of duplicate detection and key points of the process
  • Guidance on the detection of duplicates
Learning materials

CourseAdditional monitoring
Description

The course provides an introduction to additional monitoring, an insight into Member State experiences and examples of good practice from the United Kingdom's and Czechia's competent authorities. 

Main topics discussed
  • Importance of additional monitoring
  • Identifying, managing and raising awareness of ADRs for drugs subject to additional monitoring
  • Examples to optimise processes for tracking and handling of ADRs for drugs subject to additional monitoring
Learning materials

CourseAwareness levels of national ADR reporting systems
DescriptionThe course provides a strategy for NCAs to increase the number and quality of suspected ADR reports
Main topics discussed
  • Strategy to increase ADR awareness levels
  • Importance of focussing resources, stakeholder analysis and benchmarking.
  • Four pillars to raise awareness of national ADR reporting systems
  • Suggestions on how to increase ADR awareness levels
  • Running an ADR campaign
  • Measuring success
Learning materials

CourseTelephone reporting
Description

The course provides guidance on how to handle patient telephone reporting, set up a telephone service and track the number and nature of the calls received.

Main topics discussed
  • Benefits of offering a telephone reporting service
  • Types of calls received 
  • Writing down the details of an ADR report 
  • Handling a range of calls
Learning materials

The SCOPE training: IT systems for ADR reporting: Best Practice Guide offers guidance for Member States to increase their knowledge of ADR IT systems and provides insight into existing IT systems and good practice in ADR reporting.

Signal management

These training materials seek to further improve understanding of signal management within the European medicines regulatory network and develop best practice in signal management.

CourseIntroduction to signal management
Description

The course gives an overview of best practice in signal management.

Main topics discussed
  • Five steps in signal management: detection, prioritisation, validation,  confirmation and assessment.
  • Most relevant sources of information used in signal management
  • Reports of special interest
Learning materials

Risk communication

These training materials focus on risk communication practices in the EU medicines regulatory network, including the various communication channels and tools used and the effectiveness of different strategies and methods.

CourseGood practice guide on safety information for web portals
Description

The course provides guidance on developing a useful and accessible platform for presenting safety information. It highlights important considerations in developing and optimising a web platform and presents case studies from national competent authorities.

Main topics discussed
  • Introduction: knowing your audience, technical and resource considerations, legal requirements, etc
  • Compliance with minimum requirements: Directive 2010/84/EU, Good practice case studies, additional considerations
  • Presenting safety information: language style, information architecture, search functions, layout of individual webpages, etc
  • Additional tools and case studies: knowing your audience, national considerations, quality control, raising awareness and new platforms going forward.
Learning materials

Quality management systems

These training materials aim to increase existing knowledge on quality management systems and to help develop tools to support quality standards and best practice in pharmacovigilance systems.

CourseIntroduction to quality management systems
Description

The course provides basic knowledge of quality management and an understanding of how a quality management system can improve pharmacogivilance.

Main topics discussed
  • A brief history of quality management
  • Pharmacovigilance systems
  • Quality systems processes
Learning materials

CourseExchange of information between pharmacovigilance assessors and inspectors
Description

The course describes the types of marketing authorisation holder (MAH)-compliance information held by NCAs, how to access this information and the importance of information sharing between assessors and inspectors.

Main topics discussed
  • Types of MAH-compliance information
  • How to access MAH-compliance information
  • Sharing information
  • Use of checklists
Learning materials

CourseQuality planning and quality objectives
Description

The course introduces the concepts of quality policies and quality planning and highlights the importance of setting and measuring objectives. It also covers internal communication strategies.

Main topics discussed
  • Quality plans
  • Planning process and levels: from strategy to individual employees
  • How to define quality objectives and link them to the quality policy
  • Relationship between quality objectives and indicators
  • Internal communication of strategies, quality policy and objectives
Learning materials

CourseResource management 
Description

The course introduces the concept of capacity management and highlights the importance of the recruitment, training and commitment of staff. It also considers factors that influence resource allocation.

Main topics discussed
  • Capacity management
  • Recruitment, training / development and commitment of staff
  • Resource allocation
Learning materials

Life-cycle pharmacovigilance

These training materials explore the standards for pharmacovigilance assessments and examine the availability and use of data sources other than spontaneous reports in different national competent authorities.

CourseAssessment of Post-Authorisation Safety Studies (PASSs)
Description

The course explains the concept of a PASS and provides an overview of the different types of PASS.

Main topics discussed
  • Description of a PASS
  • Different types of PASS
  • Tools available to help with the assessment of a PASS.
Learning materials

CourseAssessment of periodic safety update reports (PSUR) and PSUR single assessments (PSUSA)
Description

The course summarises certain key aspects to consider when undertaking a PSUR, PSUSA or referral assessment, including the objective, questions and outcomes.

Main topics discussed
  • Purpose of PSUR assessment
  • Approaches in the assessment of a PSUR
  • Challenges of key aspects of PSUR assessment
Learning materials

CourseAssessment of risk management plans
Description

The course covers how to assess the various parts of a risk management plan, including the safety specification, missing information and the pharmacovigilance plan, and how to categorise risks.

Main topics discussed
  • Important risks regarding the benefit/risk of the product
  • Categorising important risks as identified risks or potential risks
  • How to identify patient groups for which there is missing safety information
  • Additional pharmacovigilance activities and related activities 
  • Additional risk minimisation measures and related activities.
Learning materials

CourseSafety referrals assessed by the Pharmacovigilance Risk Assessment Committee (PRAC)
Description

The course describes the various types of safety referrals procedure and the key stages in their assessment. It also provides tips on how to proceed when you are not (co)-rapporteur.

Main topics discussed
  • Purpose of a safety referral
  • Types of referral procedures
  • Key stages in a referral and how to prepare for them
  • Steps in the assessment process and drafting high quality assessment reports
Learning materials

How useful do you find this page?

Average: